FINWIRES · TerminalLIVE
FINWIRES

研究快讯:CFRA 将麦当劳公司股票评级从“持有”上调至“买入”。

By

-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师的观点总结如下:我们将目标股价下调33美元至317美元,相当于我们2026年每股收益预期值的24倍,与该股过去十年的平均远期市盈率一致。我们将2026年每股收益预期从13.44美元下调至13.21美元,并将2027年每股收益预期从14.27美元下调至14.11美元。我们将麦当劳(MCD)的评级从“持有”上调至“买入”。尽管餐厅运营成本(尤其是牛肉成本)短期内可能对利润率构成不利影响,但该股目前的交易价格较其过去十年的平均水平折让12%,因此仍是一个颇具吸引力的买入点。我们预计,随着客流量的增长和价值主张的成熟,利润率将逐步恢复正常。第一季度业绩表现优异,总收入、全球同店销售额和调整后每股收益均超出预期,其中发达市场同店销售额增长3.9%,环比提升490个基点,新兴市场也保持了3.4%的增长势头。我们认为,结果表明,价值定位在全球范围内引起了共鸣,并推动了客流量的复苏。麦当劳向鸡肉和饮料品类的扩张提供了额外的增长选择,而超过80%的自由现金流转化率则支持了对餐厅发展和股东回报的持续投资。

Related Articles

Insider Trading

Teva Pharmaceutical Industries Insider Sold Shares Worth $384,444, According to a Recent SEC Filing

Amir Weiss, Chief Accounting Officer, on May 06, 2026, sold 10,679 shares in Teva Pharmaceutical Industries (TEVA) for $384,444. Following the Form 4 filing with the SEC, Weiss has control over a total of 20,016 ordinary shares of the company, with 20,016 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/818686/000119312526211855/xslF345X05/ownership.xml

$TEVA
Research

Research Alert: CFRA Maintains Buy Opinion On Shares Of Doordash, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our price target by $2 to $240, based on 30x our 2027 EPS view, just below DASH's three-year average (~32x) given competitive threats from AI and Uber Eats, offset by the company's dominant market position and positive network effects. We raise our 2026 adjusted EPS view by $0.10 to $5.63 and 2027's by $0.06 to $7.99. We are encouraged by DASH's Q2 Marketplace GOV guidance (+36% Y/Y), an encouraging result following relatively soft guidance for Q1, especially given fears of a weakening consumer. International sales continue to scale solidly, with Deliveroo accelerating to 14% Y/Y growth in Q1 vs. 7% growth in Q4 (we expect continued improvement all year). Margin pressure remains (adjusted EBITDA margin -20 bps Y/Y to 2.4%) but should fade as platform integration activities finish up early next year. Adjusted EBITDA guidance (midpoint of $820M) was above expectations ($742M), despite the company expecting another $50M gas relief charge, which should persist amid the Strait of Hormuz closure.

$DASH
Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of Tyson Foods, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Our 12-month target remains $76, a 15x multiple of projected FY 27 EPS of $5.09 (raised by $0.02). We also lift our FY 26 (Sep.) EPS est. by $0.09 to $4.11. This multiple is slightly above TSN's long-term average of 14x, reflecting favorable secular tailwinds, including a continued shift in consumer preferences toward protein and improved earnings growth potential as the Beef segment recovers, likely in FY 27. Operationally, TSN is executing well, particularly in Chicken, where margins continue to widen, up 290 bps year over year in FQ2. Beef remains pressured by historically tight cattle supplies, with the U.S. herd at its lowest level since 1951, though we expect margins to improve following recent restructuring actions, including rightsizing production to improve capacity utilization. TSN's balance sheet is solid, noting its leverage ratio (net debt/adjusted EBITDA) has now improved to 2.2x vs. 3.9x two years ago. This provides a decent degree of financial flexibility in our view.

$TSN
研究快讯:CFRA 将麦当劳公司股票评级从“持有”上调至“买入”。 | FINWIRES